Get started
Author

Masatoshi Kitakaze

Observed names: M Kitakaze, M. Kitakaze, Masafumi Kitakaze
ORCID: 0000-0001-5157-4213
Observed ORCID: 0000-0001-5157-4213
OpenAlex ID: A5125048218
Zolbetuximab-induced gastric mucosal injury and hypoalbuminemia: a mechanism-informed clinical analysis
2026 · Yoshitomo Yanagimoto, Kazuyoshi Yamamoto, et al. · Cancer Chemotherapy and Pharmacology
335eP Tolerability and safety of adjuvant chemoradiotherapy with S-1 after limited surgery for T1 or T2 lower rectal cancer
2026 · H. Tamagawa, T. Sueda, et al. · Annals of Oncology
PDF
ASO Visual Abstract: Clinical Outcomes of First-Line Immune Checkpoint Inhibitor-Based Therapy for Postoperative Recurrence After Adjuvant Nivolumab in Esophageal Cancer
2026 · Takahito Sugase, Takashi Kanemura, et al. · Annals of Surgical Oncology
Postmortem blood examination revealed prevalence of heart failure and its comorbidities in bathing-related deaths in older Japanese adults
2026 · Ken-ichi Yoshida, Mayu Tanabe, et al. · Journal of Forensic and Legal Medicine
Early changes in albuminuria and their interaction with eplerenone treatment in patients hospitalized for acute heart failure: findings from the EARLIER trial
2025 · A Tezuka, M Kobayashi, et al. · European Heart Journal
Clinical correlates and outcomes associated with B-type natriuretic peptide changes and their interaction with eplerenone in acute heart failure: findings from the EARLEIR trial
2025 · A Tezuka, M Kobayashi, et al. · European Heart Journal
Works count: 6
Citation count:
H-index:
I10-index:
Year
Topic
Type